Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting
1 other identifier
interventional
12
1 country
1
Brief Summary
Self-monitoring of blood glucose using capillary glucose testing has a number of shortcomings compared to continuous glucose monitoring (CGM). We aimed to compare these two methods and used blood glucose measurements in venous blood as a reference. Despite considerable inter-individual variability of postprandial glycemic responses, CGM evaluated postprandial glycemic excursions which had comparable results compared to standard blood glucose measurements under real-life conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2019
CompletedFirst Submitted
Initial submission to the registry
June 24, 2019
CompletedFirst Posted
Study publicly available on registry
November 1, 2019
CompletedMay 3, 2023
May 1, 2023
6 months
June 24, 2019
May 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Postprandial glucose response
postprandial glycemic changes after consuming different carbohydrate containing foods
1 and 2 hours after food consumption
Secondary Outcomes (1)
incremental AUC (AUCi) of postprandial glucose excursions
1 and 2 hours after food consumption
Study Arms (1)
Evaluation of CGM compared with standard measurements
OTHERTwo products were studied: white bread (Butter Toast®, Golden Toast, Wittenberg, Germany) and whole grain bread (1688 Mehrkorn®, Harry-Brot, Schenefeld, Germany). One portion (containing 50 g digestible carbohydrates) was eaten immediately before the beginning of the test in the morning after an overnight fast of at least 10 h. Before testing, participants ate as usual on the previous day without a standard meal and refrained from consuming alcohol and exercising for 72 h. A 200-ml glucose drink (Accu-Chek Dextrose O.G.-T. Saft®, Roche Diabetes Care, Mannheim, Germany), containing also 50 g of carbohydrates, was used as the reference product.
Interventions
One day prior to the study beginning, participants were equipped with a CGM system (FreeStyle Libre®, Abbott Diabetes Care, Alameda, CA, USA). This CGM system provides glucose recordings every 15 min over a period of 14 days. The glucose data were downloaded manually by a scan with a handheld device. On the second day of the study, participants consumed portions of these three test products containing 50 g of available carbohydrate on 3 separate days without a washout period. The products were tested in random order at the same time of the morning after a 10 h overnight fast. Venous blood samples were collected at 0, 15, 30, 45, 60, 75, 90, 105 and 120 min postprandial by inserting an intravenous cannula into a forearm vein. Capillary blood samples were obtained through finger pricking. Blood glucose levels in these samples were measured with a high quality SMBG system (ContourXT/Contour next, Ascensia Diabetes Care, Leverkusen, Deutschland, Germany).
Eligibility Criteria
You may qualify if:
- years old
You may not qualify if:
- acute diseases, severe illness with in-patient treatment during the last 3 months, weight change \>2 kg/week during the last month, smoking secession during the last 3 months, drugs for active weight reduction, chronic medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- West German Center of Diabetes and Healthlead
- Bionorica SEcollaborator
Study Sites (1)
West-German Center of Diabetes and Health
Düsseldorf, 40591, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the West German Center of Diabetes and Health, Head of Diabetology
Study Record Dates
First Submitted
June 24, 2019
First Posted
November 1, 2019
Study Start
December 1, 2018
Primary Completion
May 31, 2019
Study Completion
May 31, 2019
Last Updated
May 3, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share